Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy.

Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy.

Item
http://www.wikidata.org/entity/Q34412294
The CD200-CD200 receptor inhibitory axis controls arteriogenesis and local T lymphocyte influx.Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions.DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth.Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesisIL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours.IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytomaIL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy.A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.Expression of CD200 on AML blasts directly suppresses memory T-cell function.Myogenic properties of human mesenchymal stem cells derived from three different sources.Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
P2860

Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy.

Item
http://www.wikidata.org/entity/Q34412294
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@ast
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@en
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@nl
type
label
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@ast
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@en
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@nl
prefLabel
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@ast
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@en
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Tumor expression of CD200 inhi ...... immune evasion of CTL therapy.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932